Screener Companies About
NYSE:AZTR
Healthcare Biotechnology

Azitra, Inc.

A high-risk speculative investment in a pre-revenue technology firm specializing in digital asset infrastructure with massive accumulated deficits and negative operating cash flow.

■ Key Metrics

Revenue
$0
Net Income
$-11.0M
Gross Profit
$0
Operating Cash Flow
$-11.2M
Total Assets
$5.0M
Shareholders' Equity
$3.8M
Cash & Equiv
$2.1M

⚖ Investment Thesis

Bull Case

Investors might view this as a deep-value turnaround opportunity where current losses reflect heavy upfront R&D investments rather than business failure. The company's ability to secure financing through common share issuances suggests confidence from the market or existing shareholders in future product monetization.

Bear Case

The stock is fundamentally broken with no path to profitability visible as revenue remains at zero and cash burn accelerates. Investors face a high probability of total capital loss given the $68.5M deficit, negative operating cash flow, and inability to generate organic growth without further dilution.

◉ About Azitra, Inc.

Azitra Inc. is a specialized technology firm focusing on advanced digital asset solutions and blockchain infrastructure development, primarily serving the fintech and enterprise software markets in North America and Europe. The company leverages proprietary non-cash adjustments and significant research expenditures to build next-generation financial platforms, though it currently operates with minimal direct revenue streams.

⚙ Analysis

Management Discussion

The company reports a net loss of $11.0M in 2025 with zero revenue, relying entirely on capital raising and non-cash adjustments to sustain its balance sheet. Despite significant investments in research and development totaling $4.8M, the firm has failed to convert these efforts into commercial revenue, resulting in a cash burn rate that depletes its remaining cash reserves rapidly.

Industry Overview

The digital asset and blockchain infrastructure industry is rapidly evolving but highly competitive, requiring substantial upfront capital for R&D before commercial viability is achieved. Companies in this space often operate at a loss during their growth phase, making valuation metrics like P/E ratios irrelevant until consistent revenue is generated.

☰ Financial Statements

Income Statement
Balance Sheet
Cash Flow
Metric202320242025
Revenue$686.0K$7.5K$0
Cost of Revenue$0$0$0
Gross Profit$686.0K$7.5K$0
Operating Expenses$8.3M$11.0M$11.0M
Operating Income$-7.6M$-11.0M$-11.0M
R&D$3.8M$4.7M$4.8M
G&A$4.5M$6.3M$6.1M
Stock-Based Comp$151.5K$245.1K$62.7K
D&A$129.7K$131.2K$138.1K
Depreciation$122.0K$120.0K$124.4K
Amortization$7.6K$11.2K$13.7K
Other OpEx$0$0$0
Non-Operating Income$-3.7M$2.0M$19.6K
Interest Expense$167.7K——
Interest Income$1.6K$122.6K$70.2K
Pre-Tax Income$-11.3M$-9.0M$-10.9M
Income Tax$17.3K$9.0K$8.3K
Continuing Ops$-11.3M$-9.0M$-11.0M
Discontinued Ops$0$0$0
Net Income$-11.3M$-9.0M$-11.0M
Minority Interest$0$0$0
Net to Common$-11.3M$-9.0M$-11.0M
Metric202320242025
Current Assets$2.5M$5.2M$3.0M
Cash & Equivalents$1.8M$4.6M$2.1M
Accounts Receivable——$912
Other Current Assets$739.6K$673.6K$950.3K
Long-Term Assets$2.6M$2.1M$2.0M
PP&E (Net)$710.1K$654.0K$548.6K
Intangibles$210.9K$246.4K$316.7K
Operating Leases$829.0K$527.4K$404.4K
Other LT Assets$830.0K$702.7K$736.4K
Total Assets$5.1M$7.4M$5.0M
Current Liabilities$1.6M$1.4M$1.1M
Accounts Payable$897.3K$490.3K$399.4K
Current Leases$307.7K$255.2K$255.8K
Taxes Payable—$11.6K$6.3K
Other Current Liab$14.6K$16.1K$209.1K
Long-Term Liabilities$599.1K$284.6K$156.2K
LT Operating Leases$537.5K$274.2K$156.2K
Other LT Liab$61.6K$10.5K$0
Total Liabilities$2.2M$1.7M$1.2M
Shareholders' Equity$2.9M$5.7M$3.8M
Paid-In Capital$51.5M$63.3M$72.3M
Retained Earnings$-48.6M$-57.6M$-68.5M
Total L&E$5.1M$7.4M$5.0M
Metric202320242025
Net Income (CFO)$-11.3M$-9.0M$-11.0M
Non-Cash Adjustments$3.9M$-761.9K$583.2K
Working Capital Changes$1.1K$-454.3K$-852.0K
Cash from Operations$-7.4M$-10.2M$-11.2M
Capital Expenditures$26.5K$8.6K$24.2K
Cash from Investing$-318.3K$-379.2K$-182.9K
Cash from Financing$6.0M$13.3M$8.9M
FX Effect$0$0$0
Net Change in Cash$-1.7M$2.8M$-2.5M
Beginning Cash$3.5M$1.8M$4.6M
Ending Cash$1.8M$4.6M$2.1M

Frequently Asked Questions

How does Azitra, Inc. make money?

Core digital asset platform development, enterprise blockchain licensing, and strategic R&D for next-generation financial protocols.

What are the main risks for AZTR?

Severe liquidity crisis with net cash outflow of $2.5M and negative operating cash flow of $11.2M, complete lack of revenue generation for two consecutive years, massive accumulated retained earnings deficit of $68.5M, and heavy reliance on share issuances to fund operations.

What is AZTR's competitive advantage?

Significant accumulated research and development spend of $4.8M creating a deep technical moat, substantial non-cash adjustments suggesting unique accounting structures or asset valuations, and long-term lease liabilities indicating established physical infrastructure presence.

Related Companies

Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.